RMD: Keybanc Maintains Overweight
Keybanc maintains overweight rating on ResMed and lowers price target to $266
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Keybanc maintains overweight rating on ResMed and lowers price target to $266
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.